Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) begins working from the first injection, but meaningful appetite changes typically appear within one to four weeks, and noticeable weight loss usually follows over the first one to three months. The speed varies between individuals depending on dose, metabolism and lifestyle. Because Mounjaro is a prescription-only medicine, a GPhC-registered prescriber assesses whether it is clinically appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've collected your first Mounjaro pen, put it in the fridge door and given yourself that initial 2.5 mg injection. The next morning you half-expect something dramatic. For most people, nothing dramatic happens, and that is completely normal.
The 2.5 mg starting dose exists primarily to let your system adjust. Nausea, which is the most commonly reported early side effect, is far more manageable at this level than it would be if treatment opened at a higher dose. Some people notice a faint sense of fullness arriving sooner at mealtimes within the first week. Others feel almost nothing at all and wonder whether the pen is working. Both experiences are within the expected range.
What is happening, even if you cannot feel it, is that tirzepatide is already activating GLP-1 and GIP receptors, slowing gastric emptying and beginning to send satiety signals to the brain. The overview of how Mounjaro works covers this mechanism in more depth. If you are curious about how quickly you feel the effects of Mounjaro, the clinical effects simply need a few weeks to become perceptible. Patience in week one is not a sign that something is wrong; it is how the medicine was designed to behave.
This is the window where most people start to notice something concrete. Portions that previously felt unremarkable become difficult to finish. The pull toward snacking in the evening weakens. Food that once felt compulsive feels easier to pass by.
These changes are not dramatic announcements, they tend to arrive quietly, which is why some patients only recognise them in retrospect. If you find yourself describing the first month on Mounjaro as unremarkable on the hunger front, look back at what you were actually eating, because the adjustment is often invisible until you notice what you did not eat.
Weight loss on the scales during this period is real but can feel slow. The body holds water as it adjusts, and the starting dose is intentionally conservative. Understanding how long it takes for Mounjaro to take effect can help set realistic expectations, since some people lose two to four kilograms in weeks two through eight, others lose more, others less. For a fuller picture of what to do if the scales are not moving as you expected, the page on not losing much weight on Mounjaro addresses the most common reasons.
Side effects, particularly nausea and changes to digestion, tend to be most noticeable in the first few days after a dose or a dose increase, and then settle. If they feel persistent or severe, that is a conversation for your prescriber, not something to push through alone.
Each four-weekly titration step (from 2.5 mg toward 5 mg, then potentially 7.5 mg and beyond) typically brings a noticeable step-up in appetite suppression. Many people describe the jump from the starter pen to 5 mg as the point where Mounjaro takes effect noticeably faster, with appetite suppression feeling like it has genuinely shifted gear.
This cumulative pattern is reflected in the trial data. SURMOUNT-1, the pivotal phase-3 study (2,539 adults over 72 weeks), showed that weight loss continued to build across the entire trial duration rather than plateauing early, with those on 15 mg reaching average reductions of around 20–21% of body weight. As the NHS tirzepatide medicines page notes, the treatment works alongside a reduced-calorie diet and increased activity, the medicine changes the appetite signal; what you do with that change shapes the outcome.
For those thinking about cost alongside effectiveness, the context around Mounjaro pricing in the UK is worth reading before making any decisions about where to access treatment.
One practical note: if you are ordering treatment through a regulated pharmacy, timing matters. Order before midday on a weekday, and once your consultation has been clinically reviewed, your pen can be dispatched the same day. That said, a prescriber at our clinical team will always assess your full picture before any treatment is approved, the speed of delivery is not a substitute for that step.
Several things can make Mounjaro feel slower to take effect than you expected. Starting at the correct dose (always 2.5 mg) means the first four weeks are by design a tolerability phase. Holding at a dose because of side effects is clinically sensible but does push back the point at which you reach a more active therapeutic level. Significant life stressors, disrupted sleep and very high-calorie diets can all blunt the appetite-reduction signal even when the medicine is working as expected.
If you are several months in, on a meaningful dose and genuinely seeing no movement on weight or appetite, that is the kind of conversation to bring to your prescriber directly. The answers are usually clinical rather than motivational, a dose review, a look at other factors, or occasionally a consideration of whether the treatment is the right fit. The general FAQs cover some of the common questions people have at this stage. For queries that need a direct response, the support team is available seven days a week.
Speak to our prescribers if you would like a clinical assessment to understand whether Mounjaro is appropriate for you, start your free consultation here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.